Rubio M - Search Results

1

tPA in the injured central nervous system: different scenarios starring the same actor?

Lemarchant S, Docagne F, Emery E, Vivien D, Ali C, Rubio M. Lemarchant S, et al. Among authors: rubio m. Neuropharmacology. 2012 Feb;62(2):749-56. doi: 10.1016/j.neuropharm.2011.10.020. Epub 2011 Nov 7. Neuropharmacology. 2012. PMID: 22079561 Review.

2

Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults.

Rubio M, Villain H, Docagne F, Roussel BD, Ramos JA, Vivien D, Fernandez-Ruiz J, Ali C. Rubio M, et al. PLoS One. 2011;6(8):e23690. doi: 10.1371/journal.pone.0023690. Epub 2011 Aug 19. PLoS One. 2011. PMID: 21886913 Free PMC article.

3

Intracerebral hematomas disappear on T2*-weighted images during normobaric oxygen therapy.

Gaberel T, Gakuba C, Hebert M, Montagne A, Agin V, Rubio M, Emery E, Vivien D, Gauberti M. Gaberel T, et al. Among authors: rubio m. Stroke. 2013 Dec;44(12):3482-9. doi: 10.1161/STROKEAHA.113.002045. Epub 2013 Oct 8. Stroke. 2013. PMID: 24105700

4

Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke.

Wyseure T, Rubio M, Denorme F, Martinez de Lizarrondo S, Peeters M, Gils A, De Meyer SF, Vivien D, Declerck PJ. Wyseure T, et al. Among authors: rubio m. Blood. 2015 Feb 19;125(8):1325-32. doi: 10.1182/blood-2014-07-588319. Epub 2014 Dec 24. Blood. 2015. PMID: 25540192 Free article.

5

Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator.

Lemarchand E, Gauberti M, Martinez de Lizarrondo S, Villain H, Repessé Y, Montagne A, Vivien D, Ali C, Rubio M. Lemarchand E, et al. Among authors: rubio m. Stroke. 2015 Jun;46(6):1641-50. doi: 10.1161/STROKEAHA.114.007143. Epub 2015 Apr 28. Stroke. 2015. PMID: 25922513

6

Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism.

Lemarchand E, Maubert E, Haelewyn B, Ali C, Rubio M, Vivien D. Lemarchand E, et al. Among authors: rubio m. Cell Death Differ. 2016 Jan;23(1):123-31. doi: 10.1038/cdd.2015.76. Epub 2015 Jun 12. Cell Death Differ. 2016. PMID: 26068590 Free PMC article.

7

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.

Maysami S, Wong R, Pradillo JM, Denes A, Dhungana H, Malm T, Koistinaho J, Orset C, Rahman M, Rubio M, Schwaninger M, Vivien D, Bath PM, Rothwell NJ, Allan SM. Maysami S, et al. Among authors: rubio m. J Cereb Blood Flow Metab. 2016 Mar;36(3):596-605. doi: 10.1177/0271678X15606714. Epub 2015 Sep 30. J Cereb Blood Flow Metab. 2016. PMID: 26661169 Free PMC article.

8

Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis.

Orset C, Haelewyn B, Allan SM, Ansar S, Campos F, Cho TH, Durand A, El Amki M, Fatar M, Garcia-Yébenes I, Gauberti M, Grudzenski S, Lizasoain I, Lo E, Macrez R, Margaill I, Maysami S, Meairs S, Nighoghossian N, Orbe J, Paramo JA, Parienti JJ, Rothwell NJ, Rubio M, Waeber C, Young AR, Touzé E, Vivien D. Orset C, et al. Among authors: rubio m. Stroke. 2016 May;47(5):1312-1318. doi: 10.1161/STROKEAHA.116.012238. Epub 2016 Mar 31. Stroke. 2016. PMID: 27032444 Free PMC article.

9

Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

Leys D, Hommet Y, Jacquet C, Moulin S, Sibon I, Mas JL, Moulin T, Giroud M, Sagnier S, Cordonnier C, Medeiros de Bustos E, Turc G, Ronzière T, Bejot Y, Detante O, Ouk T, Mendyk AM, Favrole P, Zuber M, Triquenot-Bagan A, Ozkul-Wermester O, Montoro FM, Lamy C, Faivre A, Lebouvier L, Potey C, Poli M, Hénon H, Renou P, Dequatre-Ponchelle N, Bodenant M, Debruxelles S, Rossi C, Bordet R, Vivien D; OPHELIE investigators and the STROKAVENIR network. Leys D, et al. Neurology. 2016 Dec 6;87(23):2416-2426. doi: 10.1212/WNL.0000000000003399. Epub 2016 Nov 4. Neurology. 2016. PMID: 27815401 Clinical Trial.

10

Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain.

Lecuyer M, Rubio M, Chollat C, Lecointre M, Jégou S, Leroux P, Cleren C, Leroux-Nicollet I, Marpeau L, Vivien D, Marret S, Gonzalez BJ. Lecuyer M, et al. Among authors: rubio m. Pharmacol Res Perspect. 2017 Aug;5(4):e00315. doi: 10.1002/prp2.315. Pharmacol Res Perspect. 2017. PMID: 28805973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,774 results

Search Page